Dr. Hooman Kamel, MD

Dr. Kamel practices at NewYork-Presbyterian/Weill Cornell Medical Center in New York, New York, part of NewYork-Presbyterian Hospital.

Dr. Kamel's NPI, 1275659203, was assigned on March 21, 2007. Dr. Kamel graduated from Vagelos College of Physicians and Surgeons in 2005. Dr. Kamel holds California license A99073.

Dr. Kamel's primary practice is NewYork-Presbyterian/Weill Cornell Medical Center, at 525 East 68th Street, New York, NY 10065 in New York County. The practice phone is (212) 746-5454.

Dr. Kamel's primary practice is NewYork-Presbyterian/Weill Cornell Medical Center in New York, New York, part of NewYork-Presbyterian Hospital. The medical group on file is Weill Cornell Physicians. Dmand AI also links Dr. Kamel to 2 more clinical labs and 1 hospice, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kamel practices, 4 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Kamel's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Kamel is board certified in neurology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Kamel's licenses on file in 2 states: California and New York.

Dmand AI lists acute mini-stroke (TIA), mini-stroke (TIA) and stroke among the conditions Dr. Kamel treats.

CMS data shows 179 Medicare services from Dr. Kamel across 4 procedure codes in 2024, for 89 Medicare patients. Medicare paid $26,871 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 89 Medicare patients who saw Dr. Kamel in 2024. The largest group is 65 to 74, with 27 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 31% are also on Medicaid. Their average risk score is 2.69, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kamel's median patient age at 69, with 68% women.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Kamel for performance year 2024, reported through an alternative payment model (APM). Dr. Kamel accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 518 papers to Dr. Kamel, published from 2010 to 2025. 2017 was the busiest year, with 44. The most frequent topics are Stroke, Brain Ischemia and Atrial Fibrillation. Dr. Kamel has published most often in Stroke. Dr. Kamel's most frequent co-authors are Alexander E. Merkler, Santosh Bhaskar Murthy, MD and Neal S. Parikh, MD.

Dmand AI links Dr. Kamel to 2 clinical trials, 2 of them phase 3 studies. 1 is still active or recruiting. Conditions studied include Cerebral Hemorrhage, Ischemic Stroke and Intracranial Hemorrhages. Open Payments lists research payments to Dr. Kamel that name 1 trial.

CMS Open Payments shows 150 general payments to Dr. Kamel from 9 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 66% of the total. Genentech, Inc. paid the most, $58,614. It also lists 18 research payments totaling $18,400 from 2018 to 2025, naming 1 clinical trial.

Dmand AI lists 17 awards for Dr. Kamel, most recently Siekert New Investigator Award in Stroke in 2016.

Dr. Kamel graduated from Vagelos College of Physicians and Surgeons in 2005.

Dr. Kamel is in network with 15 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.